Grant: TG: The Can. Cannabis/Brain Health Cons.- Contr.Trials Cannabis for Med purp.
University of Calgary
$2,400,000.00
CannSleep: Exploring the relationship between cannabis and sleep in a nationally representative Canadian cohort and randomized controlled trial in PTSD
FY 2025-26
Summary
Sleep problems affect nearly half of all Canadian adults and are a major contributor to poor mental and physical health. While approved sleep medications exist, many Canadians are now turning to legalized cannabis constituents (CBD, THC) to manage sleep challenges. Despite widespread use and potential short-term improvements in sleep, there is limited scientific evidence to guide safe and effective use of cannabis for sleep or how it may impact long-term mental and physical health. This gap has created uncertainty for individuals, healthcare providers, and policymakers.
This project addresses this gap through two complementary approaches. First, we will follow a large, nationally representative cohort (N=450) to observe how patterns of cannabis use relate to sleep and brain health over time using at-home sleep monitoring. Second, we will conduct a randomized, placebo-controlled trial (RCT) to determine whether oral THC or CBD can improve sleep and related brain health outcomes in people with post-traumatic stress disorder (PTSD; N=150). PTSD affects nearly 8% of Canadians and is strongly associated with chronic sleep disturbances. Many individuals with PTSD report using cannabis to manage sleep. By focusing on this population, the study will directly test whether cannabis constituents improve sleep as a central driver of adjacent mental health and physical health indicators in a subgroup of the Canadian population where the magnitude of potential benefits and risks are particularly significant.
Cannabis use is increasing across Canada, and at the same time new technologies now allow for at-home monitoring of sleep and brain activity, enabling large-scale, real-world data collection that was not previously feasible, increasing. By integrating population-level data with a RCT, this study will provide the most comprehensive evidence to date with regards to how cannabis affects sleep and brain health across diverse general and at-risk populations.
Department
Program
TG: The Can. Cannabis/Brain Health Cons.- Contr.Trials Cannabis for Med purp.
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
563603
Name
Mayo Leah M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
The Canadian Cannabis and Brain Health Consortium
Projecttitle
CannSleep: Exploring the relationship between cannabis and sleep in a nationally representative Canadian cohort and randomized controlled trial in PTSD
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$2,400,000
Cihrequipment2
$0
Programname2
TG: The Can. Cannabis/Brain Health Cons.- Contr.Trials Cannabis for Med purp.
Keyworddelim
Cannabis; Indigenous Health; Ptsd; Rct; Sleep; Stress; Trauma
Abstract
Sleep problems affect nearly half of all Canadian adults and are a major contributor to poor mental and physical health. While approved sleep medications exist, many Canadians are now turning to legalized cannabis constituents (CBD, THC) to manage sleep challenges. Despite widespread use and potential short-term improvements in sleep, there is limited scientific evidence to guide safe and effective use of cannabis for sleep or how it may impact long-term mental and physical health. This gap has created uncertainty for individuals, healthcare providers, and policymakers.
This project addresses this gap through two complementary approaches. First, we will follow a large, nationally representative cohort (N=450) to observe how patterns of cannabis use relate to sleep and brain health over time using at-home sleep monitoring. Second, we will conduct a randomized, placebo-controlled trial (RCT) to determine whether oral THC or CBD can improve sleep and related brain health outcomes in people with post-traumatic stress disorder (PTSD; N=150). PTSD affects nearly 8% of Canadians and is strongly associated with chronic sleep disturbances. Many individuals with PTSD report using cannabis to manage sleep. By focusing on this population, the study will directly test whether cannabis constituents improve sleep as a central driver of adjacent mental health and physical health indicators in a subgroup of the Canadian population where the magnitude of potential benefits and risks are particularly significant.
Cannabis use is increasing across Canada, and at the same time new technologies now allow for at-home monitoring of sleep and brain activity, enabling large-scale, real-world data collection that was not previously feasible, increasing. By integrating population-level data with a RCT, this study will provide the most comprehensive evidence to date with regards to how cannabis affects sleep and brain health across diverse general and at-risk populations.
Competitiondate
202601
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mayo, Leah M; Clarke, Hance A; Hill, Matthew N; Robillard, Rébecca
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $2,400,000~ $0~